- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06522204
Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children
December 15, 2025 updated by: Karaman Training and Research Hospital
Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children After Preoperative Precise Fluid Intake
In the recent literature, preoperative fasting times for pediatric patients are limited to one hour for clear fluids.
Studies related to gastric emptying times mostly searched for normal-weight children.
These studies have claimed that 3 mL/kg of clear liquid can be allowed up to 1 hour before surgery.
There is a lack of interest in the gastric emptying time of underweight pediatric patients during the preoperative period.
Recent studies suggest that underweight children may experience rapid gastric emptying.
This trial compares the gastric volume and emptying time after ingesting 3 mL/kg clear fluid in underweight and normal-weight pediatric patients in the preoperative period.
Study Overview
Detailed Description
After receiving informed consent from the children and their families, the American Society of Anesthesiologists (ASA) 1-2 pediatric patients between 6 and 14 years who will be recruited for elective surgery will be included in this study.
The children under the 5% percentile will be accepted as underweight.
After, the basal gastric volume will be calculated with the help of Ultrasonography (USG).
The children will receive oral 3 mL/kg 5% dextrose.
USG evaluation will be made every 5 minutes until the gastric volume reaches the basal level.
Children reaching basal gastric volume will be accepted as suitable for the surgery.
This study compares the gastric volume and emptying time after ingesting 3 mL/kg clear fluid in underweight and average-weight pediatric patients in the pre-operative period.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karaman, Turkey (Türkiye)
- Karaman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ASA physical state I or II
- Age 6 to 14 years.
- Gender: both sexes.
- Scheduled for non-gastrointestinal Tract elective day-case surgery under general anesthesia.
Exclusion Criteria:
- Parent/caregiver refusal
- Ages < 6 or > 14 years old
- Children with gastroesophageal reflux disease
- Renal failure
- Diabetes mellitus
- Cerebral palsy patients
- Mental retardation
- Esophageal strictures, achalasia, or any intestinal disease that may impair gastric emptying.
- Gastrointestinal system surgery and neurosurgical patients
- Emergency surgery
- Violation of the prescribed fasting times
- Refusing to drink prescribed clear fluid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Grup Underweight
Experimental: Underweight pediatric patient Underweight children aged 6-14 years, under 5% percentile, fasted for the night before planned surgery.
|
All the patients will receive oral 3mL/kg 5%Dextrose
Other Names:
|
|
Active Comparator: Group Normal weight
Active Comparator: Normal weight pediatric patient Normal weight children aged 6-14 years, between 5-85% percentile, fasted for the night before planned surgery.
|
All the patients will receive oral 3mL/kg 5%Dextrose
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric emptying time
Time Frame: 90 minute after Dextrose ingestion
|
Time until the gastric volume reaches the baseline level again
|
90 minute after Dextrose ingestion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antral cross-sectional area
Time Frame: Every 5 minute until the ACSA decreased to the baseline value (assessed up to 90 minute after Dextrose ingestion).
|
Antral cross-Section Area (ACSA) (cm2) maximal anteroposterior diameter (D1) and longitudinal diameter (D2) will be measured with ultrasound and calculated with that mathematical formula: ACSA(cm2) = Π x D1 x D2 / 4 |
Every 5 minute until the ACSA decreased to the baseline value (assessed up to 90 minute after Dextrose ingestion).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rafet YARIMOGLU, MD, Karaman Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 30, 2024
Primary Completion (Actual)
December 15, 2025
Study Completion (Actual)
December 15, 2025
Study Registration Dates
First Submitted
July 16, 2024
First Submitted That Met QC Criteria
July 23, 2024
First Posted (Actual)
July 26, 2024
Study Record Updates
Last Update Posted (Actual)
December 22, 2025
Last Update Submitted That Met QC Criteria
December 15, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-2023/11
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preoperative Fasting
-
SMG-SNU Boramae Medical CenterUnknownPreoperative Fasting
-
University Children's Hospital, ZurichCompleted
-
SMG-SNU Boramae Medical CenterNot yet recruitingPreoperative FastingKorea, Republic of
-
Tokat Gaziosmanpasa UniversityUnknownPreoperative FastingTurkey
-
Sheba Medical CenterWithdrawnDuration of Preoperative FastingIsrael
-
Medical University of WarsawRecruitingLiver Transplant Recipient | Preoperative Clear Fluid FastingPoland
-
Bursa Sevket Yilmaz Training and Research HospitalNot yet recruitingUpper Gastrointestinal Endoscopy | Preoperative Fasting | Gastric ResidueTurkey (Türkiye)
-
Ataturk UniversityRecruitingCesarean Section | Preoperative Fasting | ObsQor-10Turkey (Türkiye)
-
Bursa City HospitalNot yet recruitingPediatric Surgery | Preoperative Fasting | Enhanced Recovery After Surgery (ERAS) ProtocolTurkey (Türkiye)
Clinical Trials on %5 Dextrose
-
The Hospital for Sick ChildrenCompleted
-
Karaman Training and Research HospitalCompletedGastric Emptying TimeTurkey
-
Dokuz Eylul UniversityCukurova University; Kanuni Sultan Suleyman Training and Research Hospital; Baskent... and other collaboratorsCompletedFluid Therapy | Newborn Complication | Isotonic Dehydration | Hyponatremia of Newborn | Hypernatremia of Newborn | Sodium ChlorideTurkey
-
Hospital General de Niños Pedro de ElizaldeCompleted
-
Instituto Tecnologico y de Estudios Superiores...Tecnologico de MonterreyCompleted
-
Lia BallyUniversity of PadovaCompletedPost-bariatric Hypoglycaemia | Roux-en-Y Gastric BypassSwitzerland
-
McGill University Health Centre/Research Institute...CompletedSepsis | Gastroenteritis | Urinary Tract Infection | BronchiolitisCanada
-
Cairo UniversityNot yet recruiting
-
Hospital General de Niños Pedro de ElizaldeCompleted